Another approach that was proposed by Cai et al., took advantage of the fact that SIVmac239-Nef downregulates the cell surface expression of CXCR4 in tumor cells and, therefore, proliferation, migration, and angiogenesis are inhibited [73]. The gene discussed is CXCR4; the disease is neoplasm.